N'ikwekọ na ebumnuche ya, Board Editorial of MedTvoiLokony na-eme mgbalị ọ bụla iji nye ọdịnaya ahụike a pụrụ ịdabere na ya nke ihe ọmụma sayensị kachasị ọhụrụ kwadoro. Ọkọlọtọ agbakwunyere “Ọdịnaya A nyochara” na-egosi na onye dibịa enyochala ma ọ bụ dee ya ozugbo. Nkwenye nzọụkwụ abụọ a: onye nta akụkọ ahụike na dọkịta na-enye anyị ohere ịnye ọdịnaya kachasị elu nke kwekọrọ na ihe ọmụma ahụike ugbu a.
Nkwenye anyị na mpaghara a anabatala nke ọma, n'etiti ndị ọzọ, site n'aka Association of Journalists for Health, nke nyere ndị Editorial Board of MedTvoiLokony aha nsọpụrụ nke Onye Nkụzi Ukwu.
Nilogrin so na otu ọgwụ na-agbasa arịa ọbara. Ihe na-arụ ọrụ ya bụ nicergoline. Ọ bụ ọgwụ ndenye ọgwụ ma enwere ike nweta ya naanị site na ndenye ọgwụ. A na-egosi ya dị ka mbadamba ihe mkpuchi ihe nkiri ma dị na ike nke 10 mg na 30 mg. Ọ bụghị ọgwụ akwụghachi ụgwọ. Ụdị mkpọ dị iche iche dị ugbu a: 10 mg dose na ngwugwu 30, 50 na 60, yana dose 30 mg dị na ngwugwu 30.
Kedu ka Nilogrin si arụ ọrụ?
Nicergoline bụ ihe na-emepụta ihe na-emepụta ihe na-esi na ergoline ergoline ergot alkaloid. Ọ na-arụ ọrụ site na vasodilation, ya bụ ntụrụndụ nke anụ ahụ dị nro nke mgbidi arịa ọbara. N'ihi nke a omume mpụta gbasaa arịa ọbara. Nke kacha mkpa edinam eji na nkà mmụta ọgwụ bụ mmetụta Nilogrinus na cerebral arịa. Ọ bụghị naanị na ọ na-agbatị ha, kamakwa na-abawanye ojiji nke oxygen na glucose site na ụbụrụ ụbụrụ, na-eme ka metabolism ha dịkwuo mma. Nke a dị mkpa n'ịgwọ ọrịa mgbasa ọbara nke ụbụrụ nke atherosclerosis, mkpụkọ ọbara na embolism kpatara. Nilogrin bụ ọgwụ -ABỤ na ọgwụgwọ nke nsogbu ịta ahụhụ, obere nkwarụ senile na isi ọwụwa migraine vasomotor. A na-atụ aro ya na nlekọta nke ọrịa ndị na-emetụta akụkụ ahụ, dịka ọrịa Buerger - ọ bụ vasculitis thrombo-occlusive nke a na-emechi lumen nke akwara na ụkwụ, na ọrịa Raynaud (paroxysmal contractions nke arteries tumadi na vasculitis). aka), na arteriopathy nke akụkụ ahụ. Nilogrin ọ na-enwekwa mmetụta ọgwụgwọ dị ịrịba ama n'ịgwọ ọrịa na-efe efe na nku anya na n'ime ntị - dịka ọ bụrụ na tinnitus, dizziness.
Ekwesịrị ị were Nilogrin tupu nri.
Chọpụta mgbe ọ kacha mma ịṅụ ọgwụ obi
Contraindications na ịkpachara anya
Iji Nilogrinus adịghị ekwe n'oge ime na lactation. A naghị enye ụmụaka ọgwụ ahụ.
Ọ nwere ike imetụta ikike ịnya ụgbọ ala yana mebie arụmọrụ psychomotor.
obi tara mmiri ihe mgbochi do ngwa ọgwụ ahụ na-enwe mmetụta uche na nicergoline ma ọ bụ ihe ọ bụla n'ime ihe enyemaka nke ọgwụ ahụ. Nilogrinus ị nweghị ike ojiji n'ihe banyere ọrịa ndị dị ka: ọbara ọgbụgba nke ụbụrụ, hypotension, orthostatic pressure drop, bradycardia siri ike, ọnọdụ post-infarction na nso nso a.
N'ime ndị ọrịa na-aṅụ ọgwụ maka ọbara mgbali elu, ịṅụ nicergoline n'otu oge nwere ike ibelata ọbara mgbali elu nke ukwuu ma ekwesịrị ileba ya anya nke ọma - enwere ike ibelata doses nke ọgwụ mgbochi hypertensive. Nilogrin ọ nwekwara ike ịkwalite mmetụta anticoagulants, ebe ọ na-ebelata nchịkọta platelet. Biko gwa dọkịta gị nke ọma gbasara ọgwụ ị na-aṅụ, n'ihi na contraindicated bụ n'out oge ojiji Nilogrinus nwere ọgwụ α- ma ọ bụ β-adrenomimetic. Ekwesịrị ịkpachara anya mgbe ị na-aṅụ ọgwụ na-emetụta metabolism uric acid.
Mmetụta dị n'akụkụ mgbe ịṅụchara ọgwụ ahụ Nilogrin a na-ejikọta ha na oke mbelata nke ọbara mgbali na nnukwu dilatation arịa ọbara. Ihe na-emekarị bụ hypotension, bradycardia, ịda mbà n'obi, hyperhidrosis, nsogbu ihi ụra (ụra ụra na ehighị ụra nke ọma), ọkụ na-ekpo ọkụ na ịmị ọkụ, enweghị ike na mkpasu iwe, nsogbu mgbaze na mmeghachi omume hypersensitivity dị ka urticaria na erythema.
Ọ dị ezigbo mkpa icheta na mmanya na-aba n'anya nwere ike ime ka mmetụta ndị ọzọ ka njọ Nilogrinus. Onye nrụpụta ebe Nilogrin Ụlọ ọrụ ahụ bụ Polfa Pabianice.
Tupu iji ya, gụọ akwụkwọ nta ahụ, nke nwere ihe nrịbama, contraindications, data gbasara mmetụta na usoro ọgwụgwọ yana ozi gbasara ojiji nke ọgwụ ahụ, ma ọ bụ kpọtụrụ dọkịta gị ma ọ bụ onye na-ere ọgwụ, n'ihi na ọgwụ ọ bụla ejiri n'ụzọ na-ekwesịghị ekwesị na-eyi ndụ gị egwu. ahụike.